Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.
$599
Posted in: Allogeneic, BCMA, CAR-T, CD19 May 28 | 2020Thoughts on Allogene CAR-T Pipeline Update; Q1 2020 Call SummaryPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin May 27 | 2020New MPD Insulin Savings Program Supported by Lilly, Novo, and SanofiPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring May 27 | 2020Novo launches "Defeat Diabetes" campaign; Diamyd Announces DiAPREV-IT 2 Topline Results; Senseonics Releases Android Remote Monitoring AppPurchase Blast
$599
Posted in: GLP-1RA, SGLT2i May 27 | 2020CREDENCE Once Again on the CHMP Agenda; CHMP Agenda May 25-28Purchase Blast
$599
Posted in: Glucagon, Glucose Monitoring, Insulin Delivery May 22 | 2020Medtronic Guardian Connect CGM Android Approval; Xeris PBH Ph2 Results; Capillary Biomedical Initiates Extended-wear Infusion Set TrialPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery May 21 | 2020Medtronic CY Q1 '20 (FY Q4 '20) Earnings UpdatePurchase Blast
$599
Posted in: Dual/triple agonist, GLP-1RA May 15 | 2020Thoughts on High-dose Trulicity DataPurchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin May 15 | 2020Biocon Q1 '20 (FY '20) Earnings UpdatePurchase Blast
$599
Posted in: Glucagon May 14 | 2020Zealand Q1 '20 Earnings Update; Xeris Partners with ClinigenPurchase Blast
$599
Posted in: GLP-1RA May 14 | 2020Semaglutide Ph3 Obesity Positive Topline Results (STEP 4)Purchase Blast
$599
Posted in: Basal Insulin, Bolus Insulin, Glucose Monitoring May 12 | 2020Updated Perspective on Nemaura’s CGM; Lifescan and Noom Collaboration; Dario Q1 '20 Earnings UpdatePurchase Blast
$599
Posted in: Autologous, CAR-T, CD19 May 12 | 2020Thoughts on Yescarta vs Kymriah Q1 2020 Sales ComparisonPurchase Blast
$599
Posted in: Allogeneic, Autologous, BCMA, CAR-T, CD19, TCR May 12 | 2020Gilead/Kite Q1 2020 Earnings UpdatePurchase Blast
$599
Posted in: BCMA, CAR-T, CD19 May 12 | 2020Liso-Cel PDUFA 3-Month Delay; BMS Q1 2020 Call SummaryPurchase Blast$599
Posted in: Basal Insulin, Glucose Monitoring May 11 | 2020Nemaura Announces Positive Initial Data from H2H CGM Study; Mylan Q1 '20 Earnings UpdatePurchase Blast$599
Posted in: GLP-1RA May 08 | 2020High-dose Trulicity Data (AWARD-11) Published in the Journal of the Endocrine SocietyPurchase Blast
Get the Latest Analysis
Stay informed and aligned with frequent updates to keep a pulse on the industry.
If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.
